FDC Limited is a pharmaceutical company that manufactures and sells pharmaceutical products in India and around the world. The company specializes in producing formulations for different therapeutic segments, such as anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. They also produce oral rehydration salts. These specialized formulations are marketed under various brand names including Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. Additionally, FDC Limited offers anti-oxidants, balanced energy drinks, vitamins, and nutraceuticals under the brands Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich. The company also supplies various active pharmaceutical ingredients. FDC Limited was established in 1936 and has its headquarters in Mumbai, India.
Navigation section
FDC Limited
- 503.00 -9.10(-1.78%) 503.45 -8.65(-1.69%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 495.00 495.70 | 514.05 514.25 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 378.20 (20-Dec-2023) 375.65 (21-Dec-2023) | 658.85 (12-Sep-2024) 659.00 (12-Sep-2024) |
- Open
- 512.10 512.30
- Previous Close
- 512.10 512.10
- Volume
- 1.67
- Total Traded value
- 8.41 (₹ Lakhs)
- Upper circuit
- 614.50 493.50
- Lower circuit
- 409.70 329.00
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 1,001 | 0 |
| Bid Price | Quantity |
|---|---|
| 501.95 | 1,001.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 1,001 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹81.89 Cr |
| PE Ratio (TTM): | 25.98 |
| PB Ratio: | 3.58 |
| Industry P/E: | 26.34 |
| Debt to Equity: | 0.00 |
| ROE: | 13.80 |
| EPS (TTM): | 19.38 |
| Book Value: | 59.05 |
| Face Value: | 1.00 |
Financials
| Mar, 2023 | Sep, 2022 | Mar, 2023 | Sep, 2022 | Sep, 2023 | |
|---|---|---|---|---|---|
| Revenue | 327.97 Cr | 569.27 Cr | 1,789.46 Cr | 536.59 Cr | 479.70 Cr |
| Profit | 14.77 Cr | 41.90 Cr | 24.99 Cr | 15.83 Cr | 72.04 Cr |
| Expense | 307.67 Cr | 528.19 Cr | 1,758.20 Cr | 515.92 Cr | 411.85 Cr |
| Comprehensive income | 14.85 Cr | 41.84 Cr | 23.58 Cr | 15.41 Cr | 72.05 Cr |
| EPS | 2.63 | 2.65 | 1.12 | 9.73 | 4.36 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| FDC Limited | Aug, 1997 Apr, 1996 | Pharmaceuticals Pharmaceuticals | FDC FDC |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
FDC Limited FAQ's
What is the range of today's stock performance for FDC Limited?
Today's stock performance witnessed a fluctuation from a minimum of 495.00 on the NSE (National Stock Exchange) to a maximum of 514.05. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 495.70 to a high of 514.25.
What are the 52-week low and high values for FDC Limited?
The stock's performance over the past 52 weeks reveals a low of 378.20 (occurred on 20-Dec-2023) and a high of 658.85 (achieved on 12-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 375.65 (on 21-Dec-2023), and the 52-week high is 659.00 (on 12-Sep-2024).
What was the opening and previous closing prices for FDC Limited?
The stock's performance over the past 52 weeks reveals a low of 378.20 (occurred on 20-Dec-2023) and a high of 658.85 (achieved on 12-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 375.65 (on 21-Dec-2023), and the 52-week high is 659.00 (on 12-Sep-2024).
What is the total volume and traded value for FDC Limited for the day?
The total volume is 2, and the total traded value is 8.41 (₹ Lakhs).
What are the upper and lower circuit limits for FDC Limited?
The upper circuit limit is 614.50, and the lower circuit limit is 409.70.
What is the market cap and PE ratio for FDC Limited?
The market cap is ₹81.89 Cr, and the PE ratio (TTM) is 26.34.
What is the PB ratio, industry P/E, and debt to equity ratio for FDC Limited?
The PB ratio is 8.52, industry P/E is 26.34 , and the debt to equity ratio is 0.00.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for FDC Limited?
ROE is 13.80, EPS is 19.38, book value is 59.05
What are the revenue and profit figures for the latest quarter and previous quarters for FDC Limited?
In Mar 2023, Revenue is ₹3279682000.00, and Profit is ₹147738000.00. In Sep 2022, Revenue is ₹5692700000, and Profit is ₹419000000.
When was FDC Limited listed, and what industry does it belong to?
The company, FDC Limited, was listed in Aug 1997 and belongs to the Pharmaceuticals industry. Its NSE symbol is FDC.
What is the current shareholding pattern of the FDC Limited?
As of latest available update, promoters hold 69.66%, the public holds 30.34%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
